Ning et al., captured plasma derived EVs using the CD81 antibody and amplified the SARS-CoV-2 RNA by fusing with liposomes loaded with target amplification reagents, enabling accurate identification of COVID-19 patients with greater sensitivity [13]. Here, CD81 is linked to COVID-19.